Percentage of biological materials (and biofuels used for non-energy purposes) used to manufacture products and services (including packaging) that is sustainably sourced

Unit

i
: Percentage (%)

Indicator

i
: Resource consumption

Metric type

i
: Pressure

Framework alignment notes

i
Refer to the PSCI's Decarbonization Playbook for the Pharmaceutical Industry for alignment to the metric
WHO Guidance
T7

Target example

[Company name] will increase the percentage of biological materials used to manufacture products and services that are sustainably sourced by [target amount]% by [target year], compared to a [baseline year] baseline

Target Source: WBCSD target template

Sector

i
Pharmaceutical

Value chain stage

i
Raw Materials Manufacturing End of Life

Metric assessment

i

Relevance: High

Feasibility: Low

Related actions

Use recycled, renewable, or biodegradable materials to reduce reliance on virgin and fossil-based resources

Use recycled, renewable, or biodegradable materials to reduce reliance on virgin and fossil-based resources

Description

Value chain stage

Raw Materials

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce operational waste through improved material efficiency and reuse

Reduce operational waste through improved material efficiency and reuse

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Reduce APIs (including antibiotics) in the environment by designing more biodegradable pharmaceuticals that decompose faster in the environment after excretion

Reduce APIs (including antibiotics) in the environment by designing more biodegradable pharmaceuticals that decompose faster in the environment after excretion

Description

Value chain stage

End of Life

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon

Design processes and products to minimize waste and maximize circularity

Design processes and products to minimize waste and maximize circularity

Description

Value chain stage

Manufacturing

Sector of stage operator

Pharmaceutical

How the action applies

E.g., expanding use of recycled or biodegradable materials, such as for medicine delivery devices.

Engage and collaborate with suppliers to adopt innovative, sustainable, and circular materials and solutions

Engage and collaborate with suppliers to adopt innovative, sustainable, and circular materials and solutions

Description

Value chain stage

Raw Materials

Sector of stage operator

Pharmaceutical

How the action applies

Coming soon